Song Ruilin, executive chairman of China Association for the promotion of drugs, meets with CEO of Australian Biotechnology Association

Source: Song Ruilin, executive chairman of China Pharmaceutical Innovation Promotion Association (hereinafter referred to as "China pharmaceutical innovation promotion association"), met with Glenn cross, CEO of Australian Biotechnology Association (ausbiotech), who visited on October 13, 2017 The two sides had in-depth exchanges on the development of China Australia pharmaceutical industry and future cooperation between the two conferences Song Ruilin, executive chairman, pointed out that Australia's biopharmaceutical industry innovation ability ranks among the world's leading ranks, and in recent years, the cooperation between the two sides in clinical trials and other fields has been deepening In particular, the Asia Pacific region is becoming an important region for global pharmaceutical innovation The China Council for the promotion of drugs has been committed to strengthening cooperation and alliance between the Chinese pharmaceutical industry and the Asia Pacific region and the global pharmaceutical industry In particular, in 2017, China food and Drug Administration officially joined the International Coordination Council (ICH) for technical requirements of human drugs, and the regulatory standards are in line with the international standards, which will further boost the international cooperation of China's pharmaceutical industry Under this trend, we are willing to establish long-term and stable cooperative relations with the Australian Biotechnology Association, carry out substantive cooperation, and promote exchanges and cooperation between the pharmaceutical industry of the two countries President Song Ruilin held talks with Mr Glenn cross Mr cross affirmed this He introduced the Australian Biotechnology Association and said that in recent years, the willingness of cooperation between the Australian Pharmaceutical Industry and China has become stronger The cooperation between the two countries has good advantages and prospects The cooperation between the two conferences has broad space and important significance President Song Ruilin also introduced the China Pharmaceutical Innovation and investment conference and invited the Australian Biotechnology Association to participate Mr Glenn cross expressed his thanks and sincerely invited the China Council for the promotion of drugs to visit Australia The two sides will further sign a memorandum of cooperation to clarify future cooperation Tang Kai, senior manager of the Australian Embassy in China, Lu Xiaoti, director of the International Department of the China Association for the promotion of drugs, and Yuan Yuan, project director of the international department attended the meeting President Song Ruilin and Mr Glenn cross Founded in 1982, the association is composed of more than 800 member enterprises, scientific research institutions, investment institutions, law firm audit and other service institutions covering the fields of biotechnology, pharmaceutical, medical devices and other industries Guided by innovation, the association provides services for member enterprises in the fields of industrial policy-making, industrial financial services, overseas cooperation and so on In 2018, it will set up an overseas office in Shanghai.